In today’s stock market trade, a slew of stocks will be on investors’ radar, including Tata Power, Life Insurance Corporation ...

Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life bene ...

Cash Burn of $5.2 million in Q4 remains in line with projected $4-5 million quarterly rangeCash and investments on hand are sufficient to fund ...

With the right policies, advanced science, and strong leadership in government agencies, Donald Trump has the power to save ...

Target is slated to unveil its latest plan to jumpstart growth Tuesday, a crucial step in the Minneapolis-based retailer’s ...

M, +43% v. 2023; 4Q 2024 revenues of $77M, +31% v. 4Q 20232024 net income of $28M; Non-GAAP net income of $68M 4Q 2024 net ...

Target TGT.N has been sued for allegedly concealing the risks of its diversity and social initiatives, leading to a backlash that caused customers to flee and the stock price of the Minneapolis ...

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to ...

Napo has received orphan-drug designation for cholera with crofelemer ... Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on ...

WASHINGTON (AP) — The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug ...

Target (TGT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

In this article, we are going to take a look at where Target Corporation (NYSE:TGT) stands against the other large cap dividend growth stocks. Investors continue to favor large-cap stocks ...